Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Orbimed Genesis Gp Llc
Relationship:   Director, 10% Owner
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   14    
Direct Shares   0    

Indirect Shares

   54,609,900      
Direct Value   $0    

Indirect Value

   $119,618,921      
Total Shares   54,609,900      
Total Value   $119,618,921      


                                          Charting Not Avaliable
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
      
       
     Stock price went down :
      
       
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Keros Therapeutics, Inc. KROS Director 2020-04-13 0 2020-04-13 1,119,812    Premium*  
            Scpharmaceuticals Inc. SCPH 10% Owner 2020-05-21 0 2022-11-25 5,559,528    Premium*  
            Logicbio Therapeutics, Inc. LOGC Director, 10% Owner 2020-10-01 0 2020-10-01 296,296    Premium*  
            Galecto Inc. GLTO Director, 10% Owner 2020-11-02 0 2020-11-02 1,031,811    Premium*  
            Edgewise Therapeutics, Inc. EWTX Director, 10% Owner 0 2024-01-23 14,756,096    Premium*  
            Ikena Oncology, Inc. IKNA Director 2021-03-30 0 2023-08-04 7,928,543    Premium*  
            Alpine Immune Sciences Inc ALPN Director 2021-09-17 0 2024-05-18 0    Premium*  
            Theseus Pharmaceuticals, Inc. THRX Director, 10% Owner 2021-10-12 0 2024-02-14 0    Premium*  
            Janux Therapeutics, Inc. JANX Director 2021-12-16 0 2021-12-29 231,098    Premium*  
            Sierra Oncology Inc SRRA Director, 10% Owner 2022-01-26 0 2022-01-26 226,704    Premium*  
            Pmv Pharmaceuticals, Inc. PMVP 10% Owner 2022-05-26 0 2023-11-22 6,475,291    Premium*  
            Terns Pharmaceuticals, Inc. TERN Director, 10% Owner 2022-08-16 0 2022-12-23 7,619,135    Premium*  
            Disc Medicine, Inc IRON Director 2023-12-18 0 2023-12-18 1,702,237    Premium*  
            Enliven Therapeutics Ord Shs ELVN Director, 10% Owner 2023-02-23 0 2024-05-16 7,663,349    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
JANX Janux Therapeutics, Inc. Director   –       •      –    2021-12-16 4 S $19.07 $7,500,231 I/I (393,300) 245,898 0 -
JANX Janux Therapeutics, Inc. Director   –       •      –    2021-12-21 4 S $19.00 $2,268,600 I/I (119,400) 234,798 0 -
JANX Janux Therapeutics, Inc. Director   –       •      –    2021-12-29 4 S $20.30 $820,120 I/I (40,400) 231,098 0 -
PMVP Pmv Pharmaceuticals, Inc. 10% Owner   –       –       •   2022-05-26 4 S $15.93 $418,210 I/I (26,253) 87,786 0 -
IKNA Ikena Oncology, Inc. Director   –       •      –    2022-06-22 4 S $3.55 $237,161 I/I (66,806) 1,912,678 0 -
IKNA Ikena Oncology, Inc. Director   –       •      –    2022-06-23 4 S $3.71 $86,884 I/I (23,419) 1,936,097 0 -
IKNA Ikena Oncology, Inc. Director   –       •      –    2022-06-24 4 S $4.37 $803,975 I/I (162,000) 2,098,097 0 -
PMVP Pmv Pharmaceuticals, Inc. 10% Owner   –       –       •   2023-11-22 4 S $2.23 $195,763 I/I (87,786) 0 0 -
IRON Disc Medicine, Inc Director   –       •      –    2023-12-12 4 S $60.16 $1,642,368 I/I (27,300) 295,605 0 %
IRON Disc Medicine, Inc Director   –       •      –    2023-12-13 4 S $58.56 $6,248,352 I/I (106,700) 281,505 0 %
IRON Disc Medicine, Inc Director   –       •      –    2023-12-14 4 S $57.73 $11,546 I/I (200) 727,807 0 %
IRON Disc Medicine, Inc Director   –       •      –    2023-12-14 4 S $56.75 $24,584,100 I/I (433,200) 224,405 0 %
IRON Disc Medicine, Inc Director   –       •      –    2023-12-18 4 S $59.24 $102,130 D/D (1,724) 0 0 %
ALPN Alpine Immune Sciences In... Director   –       •      –    2023-12-27 4 S $19.96 $3,622,700 I/I (181,498) 406,609 0 %
ALPN Alpine Immune Sciences In... Director   –       •      –    2023-12-28 4 S $18.32 $25,049,034 I/I (1,364,849) 264,315 0 %
ELVN Enliven Therapeutics Ord ... Director   –       •       •   2024-05-16 4 S $22.14 $22,877,262 I/I (1,033,300) 7,663,349 0 -
SRRA Sierra Oncology Inc Director   –       •       •   2022-01-26 4 OE $13.20 $6,434,340 I/I 487,450 226,704 0 -
ELVN Enliven Therapeutics Ord ... Director   –       •       •   2023-05-17 4 OE $4.28 $9,095 I/I 2,125 8,663,349 0 -
IRON Disc Medicine, Inc Director   –       •      –    2023-12-18 4 OE $38.00 $65,512 D/D 1,724 1,724 0 -
ALPN Alpine Immune Sciences In... Director   –       •      –    2024-01-11 4 OE $12.74 $1,850,498 I/I 145,251 2,416,181 0 -
EWTX Edgewise Therapeutics, In... Director   –       •       •   2021-03-25 3 IO $0.00 $0 I/I 0 316,920 -
THRX Theseus Pharmaceuticals, ... Director   –       •       •   2024-02-14 4 D $0.00 $0 I/I (17,713,600) 0 0 -
ALPN Alpine Immune Sciences In... Director   –       •      –    2024-05-18 4 D $0.00 $0 I/I (2,680,496) 0 0 -
KROS Keros Therapeutics, Inc. Director   –       •      –    2020-04-13 4 B $16.00 $6,003,200 I/I 375,200 1,119,812 2.1 -
SCPH Scpharmaceuticals Inc. 10% Owner   –       –       •   2020-05-21 4 B $8.65 $11,999,998 I/I 1,387,283 231,200 1.5 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us